A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

  • Ali Amin Al Olama
  • , Zsofia Kote-Jarai
  • , Fredrick R. Schumacher
  • , Fredrik Wiklund
  • , Sonja I. Berndt
  • , Sara Benlloch
  • , Graham G. Giles
  • , Gianluca Severi
  • , David E. Neal
  • , Freddie C. Hamdy
  • , The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium
  • , The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons’ Section of Oncology
  • , The UK Protect Study Collaborators
  • , the Australian Prostate Cancer BioResource
  • , Jyotsna Batra

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Genome-wide association studies (GWAS) have identified multiple common genetic variants associated with an increased risk of prostate cancer (PrCa), but these explain less than one-third of the heritability. To identify further susceptibility alleles, we conducted a meta-analysis of four GWAS including 5953 cases of aggressive PrCa and 11 463 controls (men without PrCa). We computed association tests for approximately 2.6 million SNPs and followed up the most significantSNPs by genotyping 49 121 samples in 29 studies through the international PRACTICAL and BPC3 consortia. We not only confirmed the association of a PrCa susceptibility locus, rs11672691 on chromosome 19, but also showed an association with aggressive PrCa [odds ratio = 1.12 (95% confidence interval 1.03-1.21), P = 1.4 × 10-8]. This report describes a genetic variant which is associated with aggressive PrCa, which is a type of PrCa associated with a poorer prognosis. 
Original languageEnglish
Article numberdds425
Pages (from-to)408-415
Number of pages8
JournalHuman Molecular Genetics
Volume22
Issue number2
DOIs
Publication statusPublished - 15 Jan 2013
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease'. Together they form a unique fingerprint.

Cite this